DJ Merck & Co. Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Merck & Co. Inc. $(MRK)$ slipped 2.79% to $114.90 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.65% to 7,554.29 and the Dow Jones Industrial Average rising 0.92% to 51,671.03.
This was the stock's second consecutive day of losses.
Merck & Co. Inc. closed 8.18% short of its 52-week high of $125.14, which the company reached on February 25th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 2.16% to $235.66, Pfizer Inc. $(PFE)$ fell 0.80% to $26.00, and Eli Lilly & Co. $(LLY)$ fell 0.32% to $1,129.35.
Trading volume (15.1 M) eclipsed its 50-day average volume of 9.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 15, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 15, 2026 16:34 ET (20:34 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.